128 related articles for article (PubMed ID: 12045779)
1. Nonalcoholic steatohepatitis in nondiabetic obese patients.
Zamin I; de Mattos AA; Zettler CG
Can J Gastroenterol; 2002 May; 16(5):303-7. PubMed ID: 12045779
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.
Solis-Herruzo JA; Pérez-Carreras M; Rivas E; Fernández-Vázquez I; Garfia C; Bernardos E; Castellano G; Colina F
Am J Gastroenterol; 2005 May; 100(5):1091-8. PubMed ID: 15842583
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
4. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.
Bedossa P; Poitou C; Veyrie N; Bouillot JL; Basdevant A; Paradis V; Tordjman J; Clement K
Hepatology; 2012 Nov; 56(5):1751-9. PubMed ID: 22707395
[TBL] [Abstract][Full Text] [Related]
5. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
Giannini E; Botta F; Cataldi A; Tenconi GL; Ceppa P; Barreca T; Testa R
Hepatogastroenterology; 1999; 46(28):2422-5. PubMed ID: 10522010
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome.
Setji TL; Holland ND; Sanders LL; Pereira KC; Diehl AM; Brown AJ
J Clin Endocrinol Metab; 2006 May; 91(5):1741-7. PubMed ID: 16492691
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.
Kiyici M; Gulten M; Gurel S; Nak SG; Dolar E; Savci G; Adim SB; Yerci O; Memik F
Can J Gastroenterol; 2003 Dec; 17(12):713-8. PubMed ID: 14679419
[TBL] [Abstract][Full Text] [Related]
8. Predictors of nonalcoholic steatohepatitis in obese children.
Lerret SM; Garcia-Rodriguez L; Skelton J; Biank V; Kilway D; Telega G
Gastroenterol Nurs; 2011; 34(6):434-7. PubMed ID: 22129796
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).
Hossain N; Stepanova M; Afendy A; Nader F; Younossi Y; Rafiq N; Goodman Z; Younossi ZM
Scand J Gastroenterol; 2011 Apr; 46(4):479-84. PubMed ID: 21114431
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience.
Reha JL; Lee S; Hofmann LJ
Am Surg; 2014 Jun; 80(6):595-9. PubMed ID: 24887798
[TBL] [Abstract][Full Text] [Related]
11. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis.
Sreenivasa Baba C; Alexander G; Kalyani B; Pandey R; Rastogi S; Pandey A; Choudhuri G
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):191-8. PubMed ID: 16706832
[TBL] [Abstract][Full Text] [Related]
12. [Non alcoholic steatohepatitis].
Manero E; Findor JA; Avagnina A; de Elizalde S; Elsner B
Medicina (B Aires); 1994; 54(6):625-9. PubMed ID: 7658998
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.
Pirvulescu I; Gheorghe L; Csiki I; Becheanu G; Dumbravă M; Fica S; Martin S; Sarbu A; Gheorghe C; Diculescu M; Copăescu C
Chirurgia (Bucur); 2012; 107(6):772-9. PubMed ID: 23294957
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease in asymptomatic obese women.
Rodriguez-Hernandez H; Cervantes-Huerta M; Gonzalez JL; Marquez-Ramirez MD; Rodriguez-Moran M; Guerrero-Romero F
Ann Hepatol; 2010; 9(2):144-9. PubMed ID: 20526006
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
16. Hepatic steatosis in obese Chinese children.
Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
[TBL] [Abstract][Full Text] [Related]
17. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
[TBL] [Abstract][Full Text] [Related]
18. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients.
Campos GM; Bambha K; Vittinghoff E; Rabl C; Posselt AM; Ciovica R; Tiwari U; Ferrel L; Pabst M; Bass NM; Merriman RB
Hepatology; 2008 Jun; 47(6):1916-23. PubMed ID: 18433022
[TBL] [Abstract][Full Text] [Related]
19. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
20. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
Abd El-Kader SM; Al-Shreef FM; Al-Jiffri OH
Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]